ema semaglutide approval gives Wegovy greater flexibility in supplying patients GLP-1 shortages are not expected

In general, the self-report data indicate that medication users often report higher doses than those recorded in their EHRs, with 88.8% of semaglutide and 84.3% of tirzepatide users self-reporting a dosage greater or equal to the EHR records

Dysesthesia showed up more often on drug than placebo but was generally mild to moderate in the trial summaries

With a carefully formulated blend of berberine, chromium picolinate, gymnema sylvestre, and cinnamon extract, this dual-action supplement is gaining attention for its natural approach to appetite and metabolic support in a time when consumer demand for stimulant-free weight management solutions is at an all-time high

Reduced appetite (your brain thinks youve eaten enough)

Reduced food intake often means reduced fluid consumption from foods themselves

The medication can be taken with or without food but should not be taken in the evening, since it can raise your risk of insomnia